Sponsor or institution
Clinical trials and research at Istituto Giannina Gaslini
As of November 12, 2026, Find a Trial lists 23 clinical trials run by Istituto Giannina Gaslini that are recruiting, at sites in 17 countries (most in Italy (23), Belgium (2), Germany (2)). 19 were first registered in the last 30 days. By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 23Clinical trials
- 19New in 30 days
- 17Countries
Newest trials
All recruiting trials (23)
-
Italian Registry of Pediatric Dialysis: collecting data from kids on kidney replacement therapy
This registry in Italy tests how collecting epidemiological, clinical, and treatment data from children on dialysis or pre-emptive kidney transplants can help centers share protocols and improve care.
-
Multi-biomarkers in DEE: a big look at genetic epilepsies
This study tests a panel of multi-omic biomarkers in people with genetically confirmed Developmental and Epileptic Encephalopathy to help understand prognosis and potential biomarkers for future therapies.
-
Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions
This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.
-
Bone health in adults with Duchenne muscular dystrophy: osteoporosis, fractures, and treatment
This study looks at how common bone problems and fractures are in adults with Duchenne muscular dystrophy and what factors from childhood might affect bone health later on.
-
Seeing if CFTR functioncan be restored in CF through patient cells with rare mutations
This study tests whether testing a patient’s own nasal cells in the lab can predict if CFTR-modulator therapies might help people with uncommon CF mutations.
-
Gene editing and iPS cells to study and treat monogenic autoinflammatory diseases
Researchers are testing whether correcting disease-causing mutations in patient-derived cells can help treat autoinflammatory conditions like SAVI and COPA using gene editing and iPSC technology.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Biomarker search in SMA using advanced multi-omics
Researchers are trying to see if new biomarkers can help diagnose and monitor spinal muscular atrophy in patients and newborns.
-
Predicting the course of early-onset juvenile idiopathic arthritis using a multidimensional model
Researchers are testing a comprehensive model to predict how early-onset JIA will progress in affected children and how a small control group with iridocyclitis compares.
-
AI tools to read brain MRIs in epilepsy
Researchers are testing AI programs to help doctors read brain MRI scans in people with epilepsy to see if they can speed up diagnosis and help plan treatments.
-
Neuroblastoma patients' genomic and biological profile study
This multicenter, prospective study tests profiles from blood, tumor tissue, and bone marrow to understand neuroblastoma in diagnosed, relapsed, or refractory patients.
-
National Registry for Noonan Syndrome (Italy)
This registry will collect genetic and clinical information from people with Noonan syndrome in Italy to understand how the condition changes over time and how treatments like growth hormone may work.
-
Neuroradiology Features in Noonan Syndrome and Gene-Linked Brain Differences
This study tests brain MRI and MR angiography in people with Noonan syndrome to see how brain imaging patterns relate to their specific genetic mutations.
-
Genetic Basis of MIS-C in Children linked to COVID-19
This study tests whether genetic factors contribute to MIS-C in children who have had COVID-19.
-
Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study
This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.
-
Alexithymia and emotional dysregulation in children with epilepsy
This study tests how alexithymia and emotional regulation relate to epilepsy in kids aged 10–18 and compares them with healthy peers.
-
Understanding congenital bone marrow failure and related disorders through a national network
This project tests whether people with rare inherited bone marrow failure syndromes or related conditions really have the underlying genetic causes, by collecting data and samples across multiple centers.
-
Newborn screening for AADC deficiency in Liguria
This project tests a newborn screening approach for AADC deficiency in Liguria to see if many newborns can be identified early and referred for care.
-
DNA sequencing of patient and family samples to help diagnose rare genetic diseases
We’re testing whether whole-exome or whole-genome sequencing of patients and their parents can help diagnose rare genetic diseases when other findings are not yet clear.
-
How the CF medicines elexacaftor, tezacaftor, and ivacaftor behave in the body
This study tests how the CF medicines elexacaftor, tezacaftor, and ivacaftor move through the body in patients with cystic fibrosis who are already taking the combination therapy.
-
Pediatric Skull Fracture Detection with Ultrasound in the Emergency Department
This study tests whether point-of-care skull ultrasound can accurately detect skull fractures in children with minor head injuries compared with CT scans.
-
Sucrosomial iron for children with celiac disease and iron deficiency
This trial tests whether adding oral Sucrosomial® (Sideral forte®) iron drops to a gluten-free diet helps children aged 8–18 with newly diagnosed celiac disease and low iron or anemia recover hemoglobin and iron stores faster than diet alone.
-
ADRIS 2.1 driving simulator for adolescents with ADHD.
This project will test whether the ADRIS 2.1 driving simulator can measure and train driving-related skills in adolescents aged 13–18 with ADHD.
Quick answers
How many clinical trials run by Istituto Giannina Gaslini are recruiting right now?
23, as of November 12, 2026. 19 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in Italy (23 trials), Belgium (2 trials), Germany (2 trials), Spain (2 trials), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.